In a TV interview, pediatric asthma participant Elajah Smithwick-Bey enthusiastically demonstrates how she uses the emocha app to help her take her asthma medication every day, as part of a program between LifeBridge Health and emocha. As fewer children currently attend school in-person, they cannot participate in school-based asthma programs where DOT is administered by school nurses. Initial findings from the program with LifeBridge demonstrate that emocha’s asynchronous DOT not only delivers comparable rates to in-person DOT, but also helps reduce ER visits for children with asthma. As emocha’s CEO Sebastian Seiguer says, “This study shows you can deliver directly observed therapy in an efficient way that doesn’t burden the health care system and takes about a minute for the patient.”

Watch the interview and read the article on WMAR2 News